Global Cardiac Imaging Software Market Size, Forecast, and Trend Highlights Over 2025-2037
Cardiac Imaging Software Market size was valued at USD 626.1 million in 2024 and is poised to reach USD 1.72 billion by 2037, registering more than 8.8% CAGR during the forecast period, i.e., 2025-2037. In 2025, the industry size of cardiac imaging software is estimated at USD 681.2 million.
The increasing adoption of a sedentary lifestyle encompasses intermediate risk factors such as raised blood pressure, raised blood glucose, raised blood lipids, and obesity. These comorbidities are further diagnosed through imaging devices that help in the detection of a heart attack, stroke, heart failure, and other complications. Thus, the heightening impact of cardiovascular diseases (CVDs) is expected to drive demand in the market significantly. According to the World Heart Federation, this condition took over 20.5 million lives in 2021, accounting for almost 33.3% of total worldwide deaths. Further, the world is projected to witness 90.0%, 73.4%, and 54.7% increments in prevalence, crude mortality, and crude disability-adjusted life years (DALYs), respectively, between 2025 and 2050 (NLM).
Currently, growing incidences of cardiac arrests in the pediatric population are also expected to increase business flow in the cardiac imaging software market. To combat the widespread, many multi-national companies are now concentrating towards new product advances to pose a strong foothold over this merchandise. More technological innovations and affordable options are being introduced, which embark on continuous development and wide adoption. For instance, in February 2024, Royal Philips launched a cost-effective diagnostic system, Philips CT 5300, while providing more accurate and reliable imaging results, even in complex cardiac cases. This multifunctional tool is powered by exceptional AI capabilities streamlining workflow efficiency in diagnosis, interventions, and screenings.
Cardiac Imaging Software Sector: Growth Drivers and Challenges
Growth Drivers
- Continuous upgradation in pipelines: On the back of advancements in cloud computing and generative AI that enable shortened exam times and improved imaging in compact design, the cardiac imaging software market is expected to grow robustly. The new generation software allows automatic and contemplated analysis of structural and functional change of the heart to help understand and predict future and present possibilities of developing life-threatening conditions. Additionally, ongoing R&D activities to make systems more user-friendly and affordable are anticipated to boost adoption and reach in this sector. For instance, in October 2024, TeraRecon extended the capabilities of its Intuition platform by adding a semi-automated cardiac MRI workflow.
- Shifting consumer preference toward less-invasiveness: As more patients seek shorter hospital stays and less blood loss, the emergence of minimally invasive solutions becomes more influential, stimulating growth in the cardiac imaging software market. The non-invasive diagnostic procedures such as MRI, CT scans, and echocardiograms align with this surge. On the other hand, the trend of digitalization in healthcare is empowering the penetration of cloud and AI in this category. Thus, these factors are conjugately contributing to the increased acceptance of this field in medical settings across the world. This can be testified by the dominance of the cardiac monitoring and diagnosis segment in the cardiovascular digital solutions industry by 2037.
Challenges
- Stringent compliance criteria: For global scale distribution, alignment with various regulatory body standards is essential. However, this becomes a tedious process due to the concerns about data breaching, limiting the growth of the cardiac imaging software market. Frameworks such as HIPPA and GDPR impose strict requirements for information protection to ensure privacy, which may result in additional expenses and delays in commercialization.
- Limitations in complete integration: The new-generation tools from the cardiac imaging software market require a skilled workforce for efficient operation and management. The complex data processing and configuration of these computer platforms often fail to showcase their full potential due to the shortage of trained operators. This may present difficulties for resource-constrained healthcare settings, particularly in underserved regions, in adopting them.
Cardiac Imaging Software Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
8.8% |
|
Base Year Market Size (2024) |
USD 626.1 million |
|
Forecast Year Market Size (2037) |
USD 1.72 billion |
|
Regional Scope |
|
Cardiac Imaging Software Segmentation
Imaging Type (Tomography, Ultrasound Imaging, Radiographic Imaging, Combined Modalities)
Based on the imaging type, the tomography segment is expected to generate a significant revenue for the cardiac imaging software market over the assessed timeline. This segment is augmenting leadership with continuous technological advancements and a broad range of applications. A 2022 NLM review of randomized clinical trials on the use of cardiac computed tomography (CCT) revealed that it has the potential to decrease coronary artery disease (CAD) mortality by 41.0%. Besides, this method is also proven to be effective for preventing myocardial infraction and acute chest pain. It makes this sub-type a priority for global leaders, imposing greater business opportunities. Furthermore, the integration of AI and machine learning (ML) into these imaging systems is revolutionizing their efficiency in both clinical and research utilities.
End users (Hospitals, Cardiovascular Clinics, Echocardiography, Vascular Laboratories, Diagnostic Laboratories, Ambulatory Surgical Centers)
In terms of end users, the hospitals segment is predicted to dominate the cardiac imaging software market by the end of 2037. The growing expenditure on these organizations for infrastructural development from both public and private investors is ensuring a stable cash flow in this sub-category. Being a primary point-of-care for patients, this segment is affiliated with several government subsidies, which attracts patients for attaining services. It also represents a large consumer base and lucrative scopes of investment for this sector. This can be testified by the 2021 report from Invest India, which highlighted a USD 32.0 billion worth of 582 investment opportunities in nationwide medical infrastructure. Similarly, IBEF reported that the hospital industry in India is projected to reach USD 193.5 billion by 2032.
Our in-depth analysis of the global cardiac imaging software market includes the following segments:
|
Imaging Type |
|
|
End users |
|
Companies Dominating the Cardiac Imaging Software Landscape
- Siemens Healthcare
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Toshiba
- GE Healthcare
- Philips Healthcare
- Epsilon Imaging
- Shimadzu Corporation
- Circle Cardiovascular Imaging Inc.
- CardioComm Solutions Inc.
- Integer Holdings Corporation
- McKesson Corporation
- Exo Healthcare
The cardiac imaging software market is evolving with the ongoing technological upgrades in existing pipelines. Key players in this merchandise are leveraging their pace of development to solidify their global presence and portfolio. They are also focusing on attaining maximum regulatory compliance for seamless globalization. For instance, in August 2024, GE Healthcare gained CE marks for its Vscan Air SL wireless handheld ultrasound system with Caption AI from the European Union. Further, in the month of September, the company displayed both the Revolution Apex platform and Vscan Air SL at the European Society of Cardiology (ESC) Congress in London. Such commercial expansion is influencing other competitors to bring new products into the market. This cohort of pioneers includes:
In the News
- In April 2025, Exo received FDA 510(k) clearance for adding Global Longitudinal Strain (GLS) analysis abilities to its Exo Iris ultrasound device. This SweepAI-based GLS auto-quantification feature is intended to serve clinicians with instant, bedside cardiac insights for faster and precise diagnosis of heart failure and cardiotoxicity.
- In March 2025, GE Healthcare introduced a new CT system, Revolution Vibe, with unlimited one-beat cardiac imaging. It is backed by the company's revolutionary AI-powered solutions, including ECG-less Cardiac, TrueFidelity DL, SnapShot Freeze 2, and Effortless Workflow, to deliver a fast, comfortable, and accurate diagnosis.
- In February 2025, Philips strengthened its MRI portfolio through the launch of a new AI-powered MRI acceleration software, SmartSpeed Precise, at the 2025 European Congress of Radiology (ECR). This next-generation solution is powered by dual-AI engines to offer faster scans and higher image quality.
Author Credits: Radhika Pawar
- Report ID: 1331
- Published Date: Apr 10, 2025
- Report Format: PDF, PPT
